[Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy]

Riferimento: 
Orv Hetil. 2011 Mar 6;152(10):407-10.
Autori: 
Raizer G1, Igaz P, Pregun I, Dabasi G, Rácz K.
Fonte: 
Orv Hetil. 2011 Mar 6;152(10):407-10.
Anno: 
2011
Azione: 
Trattamento con analogi della Somatostatina determina una regressione completa del tumore primario allo stomaco e delle metastasi epatiche entro due anni.
Target: 
Somatostatina analogi/tumore primario allo stomaco e metastasi epatiche.

ABSTRACT
Somatostatin analogues represent a major treatment modality in the therapy of neuroendocrine tumors. Their efficacy is well documented in the inhibition of hormone secretion; however, novel data seem to underline their effectiveness in tumor regression, as well. In this report authors present a case of type 1 neuroendocrine tumors of the stomach associated with liver metastases. Somatostatin analogue treatment resulted in a complete regression of the primary tumor and the metastases within two years. This case draws attention on the importance of somatostatin analogue treatment not only in the control of hormonal symptoms but also in the inhibition of tumor growth.
Free full text